News and Press
Career Opportunities
Company Profile
Patient Information
Investor Information
Physician Information
Contact Us

The company's all-encompassing education program plays a critical role in bringing the benefits of minimally invasive bypass surgery to a growing number of patients. The company has developed the CTS Comprehensive Optimal Revascularization (CORsm) CORriculum Institute, which teach surgical teams key aspects of the procedure and provides them with a thorough understanding of how to implement their own high-quality, minimally invasive beating-heart programs at their centers in the shortest period of time.

The CTS CORriculum Institute sessions consist of a 1.5 day, hands-on training workshop presented by recognized authorities in minimally invasive cardiac surgery. The program includes a comprehensive didactic format ranging from patient selection to patient discharge. The course also enables each surgical team to observe actual MIDCAB™ procedures using the CTS MIDCAB System to ensure a thorough understanding of the operating setup and staff requirements. By observing actual surgeries, physicians gain a greater understanding of the requirements needed to launch programs at their own centers. Follow-up training is also provided to offer individualized support to surgical teams as they establish CTS MIDCAB programs at their institutions

The first CTS CORriculum Institute, which sold out two months in advance, was held in December at the Washington Hospital Center in Washington, D.C. In January 1997, CTS held its first international CORriculum training program at the Hannover Medical School in Hannover, Germany. By the end of 1997, CTS expects to train more than 300 surgical teams to use the CTS MIDCAB System.

CTS' comprehensive education and training will continue to play an integral role in facilitating widespread adoption of the CTS MIDCAB System and will expand to encompass other CTS technologies. The sellout of COR programs worldwide is a testament to the growing demand from cardiac surgeons for this minimally invasive treatment alternative.

Home - News & Press - Company Profile - Products - Physician Info
Patient Info - Investor Info - Contact Us